Successful Completion of Institutional Placement
Summary
If shareholders approve the issuance of New Shares under the Conditional Placement, settlement will occur shortly after an Extraordinary General Meeting, which is scheduled to occur on or around Wednesday, 22 January 2025.Following the successful completion of the Institutional Placement, the Companys shares will recommence trading on the ASX today and the Company has requested that the trading halt be lifted on opening of the market today.Citigroup Global Markets Australia Pty Limited and Jefferies (Australia) Pty Limited (together, the Joint Lead Managers) acted as joint lead managers, bookrunners and underwriters to the Institutional Placement.As announced on Tuesday, 26 November 2024, NOVONIX will separately offer a non-underwritten Share Purchase Plan (SPP) to eligible shareholders in the Company with a registered address in Australia and New Zealand as at 7.00pm (Sydney, Australia time) on Monday, 25 November 2024.The SPP aims to raise approximately A$5.0 million and will provide each eligible shareholder with the opportunity to apply for up to $30,000 worth of NOVONIX shares. Through advanced R&D capabilities, proprietary technology, and strategic partnerships, NOVONIX has gained a prominent position in the electric vehicle and energy storage systems battery industry and is powering a cleaner energy future.To learn more, visit us at www.novonixgroup.com or on LinkedIn and X.This announcement contains certain forward-looking statements that are based on managements belief, assumptions, opinions and expectations and on information currently available to management and speak only as of the date of this announcement. You are strongly cautioned not to place undue reliance on forward-looking statements.No representation is made by NOVONIX or the Joint Lead Managers or any of their respective related bodies corporate, shareholders or affiliates, or any of each of their respective officers, directors, partners, employees, consultants, contractors, affiliates, agents, advisers or representatives (each a Limited Party and together, the Limited Parties) as to the correctness of the forward-looking statements on or after the date of this announcement. To the maximum extent permitted by law, each of NOVONIX, the Joint Lead Managers and each of their respective Limited Parties disclaim any responsibility to update or revise any forward-looking statement to reflect any change in NOVONIXs financial condition, status or affairs or any change in the events, conditions or circumstances on which a statement is based, except as required by Australian law.Not for distribution or release in the United StatesThis announcement has been prepared for publication in Australia and may not be released or distributed in the United States. This includes, without limitation, any responsibility or liability arising from fault, negligence or negligent misstatement, for any loss (whether foreseeable or not and whether direct, indirect, incidental, consequential, special or economic loss or damage) including, without limitation, any loss of profit or anticipated profit, fines or penalties, loss of business or anticipated savings, loss of use, business interruption or loss of goodwill, bargain or opportunities, arising from the use of, or reliance on anything contained in or omitted from, this announcement or its contents or otherwise arising in connection with it; (2) disclaim any obligation or undertaking to release any updates or revisions to the information in this announcement to reflect any change in expectations or assumptions; and (3) do not make any representation or warranty (whether express or implied) in this announcement as to the fairness, currency, accuracy, timeliness, reliability or completeness of any information, opinions or conclusions in this announcement (including the accuracy, likelihood of achievement or reasonableness of any forecast returns, yields, future income or other statements in relation to future matters) nor do they make any representation or warranty (whether express or implied) that this announcement contains all material information about NOVONIX or which a prospective investor may require in evaluating a possible investment in NOVONIX or the acquisition of securities in NOVONIX, or in respect of the likelihood of fulfilment of any forward-looking statement or any event or results expressed or implied in any forward-looking statement.This announcement does not form the basis of any contract or commitment, nor does it contain any financial product or investment advice.